Actively Recruiting
Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD
Led by Tel Aviv University · Updated on 2025-05-16
40
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
T
Tel Aviv University
Lead Sponsor
W
Weizmann Institute of Science
Collaborating Sponsor
AI-Summary
What this Trial Is About
This RCT investigates whether Cognitive Processing Therapy, a first line treatment for PTSD, can be enhanced by the use of the odor molecule Hexadecenal (HEX). HEX is secreted from body odor and has been shown to promotes psychological well-being and positive social interaction. For the active group Hex will be diffused in the treatment room during all treatment sessions. For the control group a vehicle placebo molecule will be diffused. Both therapists and patients will be blind to study condition.
CONDITIONS
Official Title
Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of PTSD according to DSM-5
- Age 18 years and over
- Eligible for CPT treatment at the National Center for Traumatic Stress and Resilience
You will not qualify if you...
- Bipolar disorder, psychosis, neurological disorders
- Drug Addiction
- Parallel psychotherapy
- Congenital or acquired anosmia.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tel Aviv University
Tel Aviv, Israel, 69978
Actively Recruiting
Research Team
Y
Yair Bar Haim, PhD
CONTACT
N
Noga Zuk Barkan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here